Skip to main content
NVDA-2.26%AAPL+3.21%GOOGL+0.77%MSFT-0.04%AMZN-0.40%TSM-1.36%SPCX+0.37%AVGO-0.72%META-1.33%TSLA-1.04%SKHY-4.44%MU-4.49%BRK-B0.00%LLY+0.20%JPM-0.48%WMT-0.02%AMD-3.11%V-0.12%XOM+0.79%ASMLa-1.66%JNJ-0.20%INTC-5.00%MA-0.45%0700.HK-1.94%1398.HK+0.79%ORCL-4.82%ABBV+1.36%BAC-0.30%CSCO-1.41%CVX-0.30%COST-0.12%KO+0.49%LRCX-5.25%CAT-1.33%AP2d-1.55%0005.HK-0.78%AMAT-2.77%UNH-0.89%HSBA.L-1.30%DELL-4.01%PG+0.19%MS-1.04%GE-0.53%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.14%HD-1.74%0939.HK+1.66%GS-1.17%NZDJPY-2.63%AUDJPY-1.87%CHFJPY-1.61%NZDCAD-1.45%EURNZD+1.43%NZDUSD-1.42%GBPNZD+1.37%GBPJPY-1.26%EURJPY-1.25%USDJPY-1.24%CADJPY-1.20%NZDCHF-1.05%USDZAR+1.04%USDSEK+0.95%USDNOK+0.90%EURZAR+0.85%AUDNZD+0.79%GBPZAR+0.76%EURSEK+0.76%EURNOK+0.71%USDTHB+0.70%AUDCAD-0.70%AUDDKK-0.66%AUDUSD-0.64%EURAUD+0.63%CHFSEK+0.60%GBPAUD+0.59%USDMXN+0.58%CHFNOK+0.56%AUDSGD-0.56%USDPLN+0.45%GBPTRY+0.41%NZDSGD-0.41%CADCHF+0.40%USDCHF+0.39%NOKJPY-0.39%EURCHF+0.36%GBPCHF+0.33%GBPHKD+0.32%USDSGD+0.29%GBPMXN-0.28%EURPLN+0.26%AUDCHF-0.26%SGDJPY+0.22%EURHKD-0.19%USDDKK+0.19%USDILS+0.16%NZDMXN-0.13%USDTRY+0.11%USDCNH+0.10%EURSGD+0.10%GBPCAD-0.09%EURCNH-0.06%PLNJPY+0.06%AUDNOK+0.06%EURCZK-0.06%CHFSGD-0.05%EURCAD-0.05%EURGBP+0.04%USDCOP-0.04%GBPUSD-0.04%USDCAD-0.02%EURUSD-0.02%USDHKD+0.02%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.18%UKOIL+5.85%USOIL+5.68%GAGUSD-5.47%XAGUSD-5.47%HG1-4.85%XAUUSD-1.74%GAUUSD-1.74%XNGUSD+1.59%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.36%ETHUSD-0.01%USDTUSD-0.02%XRPUSD-2.86%SOLUSD-1.55%TRXUSDT+0.21%ZECUSDT-9.15%DOGEUSD-2.40%XMRUSDT+0.31%LINKUSD-1.28%XLMUSD-1.47%BCHUSDT-9.71%LTCUSD-1.65%UNIUSD-0.88%TONUSD+24.88%HBARUSDT-2.05%SUIUSD-4.19%TAOUSDT-5.53%AAVEUSD-1.81%DOTUSDT-1.74%ICPUSDT-0.47%ONDOUSDT-3.29%WLDUSDT-3.39%ATOMUSDT-3.00%ARBUSDT-0.64%JUPUSDT-3.39%INJUSDT-2.11%STXUSDT-4.53%FETUSDT-2.80%TIAUSDT-1.13%PYTHUSDT-1.22%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.61%WIFUSDT-4.89%OPUSDT-4.00%POLUSDT-4.54%IOTAUSDT-4.02%AXSUSDT-2.25%FARTCOINUSDT-2.66%EOSUSDT-2.78%DYDXUSDT-2.47%ORDIUSDT-0.86%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.26%AAPL+3.21%GOOGL+0.77%MSFT-0.04%AMZN-0.40%TSM-1.36%SPCX+0.37%AVGO-0.72%META-1.33%TSLA-1.04%SKHY-4.44%MU-4.49%BRK-B0.00%LLY+0.20%JPM-0.48%WMT-0.02%AMD-3.11%V-0.12%XOM+0.79%ASMLa-1.66%JNJ-0.20%INTC-5.00%MA-0.45%0700.HK-1.94%1398.HK+0.79%ORCL-4.82%ABBV+1.36%BAC-0.30%CSCO-1.41%CVX-0.30%COST-0.12%KO+0.49%LRCX-5.25%CAT-1.33%AP2d-1.55%0005.HK-0.78%AMAT-2.77%UNH-0.89%HSBA.L-1.30%DELL-4.01%PG+0.19%MS-1.04%GE-0.53%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.14%HD-1.74%0939.HK+1.66%GS-1.17%NZDJPY-2.63%AUDJPY-1.87%CHFJPY-1.61%NZDCAD-1.45%EURNZD+1.43%NZDUSD-1.42%GBPNZD+1.37%GBPJPY-1.26%EURJPY-1.25%USDJPY-1.24%CADJPY-1.20%NZDCHF-1.05%USDZAR+1.04%USDSEK+0.95%USDNOK+0.90%EURZAR+0.85%AUDNZD+0.79%GBPZAR+0.76%EURSEK+0.76%EURNOK+0.71%USDTHB+0.70%AUDCAD-0.70%AUDDKK-0.66%AUDUSD-0.64%EURAUD+0.63%CHFSEK+0.60%GBPAUD+0.59%USDMXN+0.58%CHFNOK+0.56%AUDSGD-0.56%USDPLN+0.45%GBPTRY+0.41%NZDSGD-0.41%CADCHF+0.40%USDCHF+0.39%NOKJPY-0.39%EURCHF+0.36%GBPCHF+0.33%GBPHKD+0.32%USDSGD+0.29%GBPMXN-0.28%EURPLN+0.26%AUDCHF-0.26%SGDJPY+0.22%EURHKD-0.19%USDDKK+0.19%USDILS+0.16%NZDMXN-0.13%USDTRY+0.11%USDCNH+0.10%EURSGD+0.10%GBPCAD-0.09%EURCNH-0.06%PLNJPY+0.06%AUDNOK+0.06%EURCZK-0.06%CHFSGD-0.05%EURCAD-0.05%EURGBP+0.04%USDCOP-0.04%GBPUSD-0.04%USDCAD-0.02%EURUSD-0.02%USDHKD+0.02%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.18%UKOIL+5.85%USOIL+5.68%GAGUSD-5.47%XAGUSD-5.47%HG1-4.85%XAUUSD-1.74%GAUUSD-1.74%XNGUSD+1.59%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.36%ETHUSD-0.01%USDTUSD-0.02%XRPUSD-2.86%SOLUSD-1.55%TRXUSDT+0.21%ZECUSDT-9.15%DOGEUSD-2.40%XMRUSDT+0.31%LINKUSD-1.28%XLMUSD-1.47%BCHUSDT-9.71%LTCUSD-1.65%UNIUSD-0.88%TONUSD+24.88%HBARUSDT-2.05%SUIUSD-4.19%TAOUSDT-5.53%AAVEUSD-1.81%DOTUSDT-1.74%ICPUSDT-0.47%ONDOUSDT-3.29%WLDUSDT-3.39%ATOMUSDT-3.00%ARBUSDT-0.64%JUPUSDT-3.39%INJUSDT-2.11%STXUSDT-4.53%FETUSDT-2.80%TIAUSDT-1.13%PYTHUSDT-1.22%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.61%WIFUSDT-4.89%OPUSDT-4.00%POLUSDT-4.54%IOTAUSDT-4.02%AXSUSDT-2.25%FARTCOINUSDT-2.66%EOSUSDT-2.78%DYDXUSDT-2.47%ORDIUSDT-0.86%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%
CT

Capricor Therapeutics, Inc. (CAPR)

NASDAQ • Healthcare

$8.64
-$0.41 (-4.6%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$9.08
Previous Close$8.64
Day Range$8.6 - $9.27
Avg. Volume (3M)11.6M
Market Cap$484.8M
52 Week Range
$2.96$40.37
Next EarningsIn 60 daysNov 9, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$129.4M
EPS (TTM)
-$2.45
ROA (TTM)
-35.1%
Current Ratio
7.35

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-21.6%Q1 2026-$0.62
-7.3%Q2 2026-$0.59
-18.9%Q3 2026-$0.7
Next

Nov 9

in 60 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc. is a small-cap biotechnology company listed on NASDAQ as CAPR that develops cell and exosome-based therapeutics. Its work centers on rare and serious diseases, with a pipeline built around programs aimed at Duchenne muscular dystrophy and other conditions with unmet medical needs.

Name
Capricor Therapeutics, Inc.
CEO
Linda Marbán
Website
www.capricor.com
Industry
Healthcare
Year Founded
1996
Employees
231

Today's Snapshot

AI-generated

CAPR is trading 5.2% below yesterday's close, in line with a weaker sector. SBS Law, a securities law firm, invited Capricor Therapeutics investors to join a securities-fraud lawsuit.

Trading Volume

Below 10d avg (4.7M)

1.8M

vs S&P 500 Today

Strong Underperformance

-4.54%

Updated: September 10, 2026 at 19:24 UTC

Technical Indicators

0 Buy3 Neutral5 Sell
CAPR is trading near $8.31 and the technical picture favors selling pressure as price sits below most short and long moving averages and beneath the pivot and VWAP. Momentum indicators are subdued or negative, and ATR is elevated, indicating above‑normal intraday swings that accompany the weakness; ADX shows only modest trend strength, while OBV provides a lone positive datapoint that fails to offset the pervasive bearish bias. Together these signals support the strong sell characterization. Technical takeaway: Strong Sell.
All signals
  • EMA (5 indicators)$8.80 - $17.62
    Sell
  • RSI (14)43.94
    Neutral
  • Stochastic %K (14, 3, 3)53.37
    Neutral
  • MACD Level (12, 26)-0.37
    Neutral

Peers & Related Assets

ALLOAllogene Therapeutics, Inc.
$1.73-7.0%
EDITEditas Medicine, Inc.
$2.77-8.6%
ARCTArcturus Therapeutics Holdings Inc.
$14.74-5.7%
LXEOLexeo Therapeutics, Inc. Common Stock
$4.48-5.9%
VNDAVanda Pharmaceuticals Inc.
$5.25-1.5%
TRDAEntrada Therapeutics, Inc.
$7.11-5.5%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.